| Title: | Integrating multi-omics analysis to identify potential biomarkers and regulatory networks of ischemic stroke |
| Journal: | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
| Published: | 20 May 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42167472/ |
| DOI: | https://doi.org/10.1016/j.pnpbp.2026.111751 |
Publication 19978
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Ischemic stroke (IS) is a leading cause of death and long-term disability worldwide, with a complex and multifactorial pathophysiology that is still incompletely understood. This study performed untargeted metabolomics and Olink proteomics on serum samples from IS patients and controls, and additionally analyzed single-nucleus RNA sequencing data from rat models of cerebral ischemia to explore cell-type-specific expression patterns. We identified 142 differentially expressed metabolites (FDR-corrected) and 24 proteins that were differentially expressed at nominal significance (P < 0.05). Using machine learning, five metabolites and IL-6 were selected as candidate biomarkers. A combined random forest model incorporating these five metabolites and IL-6 demonstrated good discriminatory performance in the external validation cohort (AUC = 0.85). In prospective analyses of the UK Biobank, higher levels of IL-6 were significantly associated with IS risk, and the hub genes (e.g., PYGL and ENO1) were enriched in pathways such as glycolysis and HIF-1 signaling. Single-nucleus RNA sequencing from rat models of cerebral ischemia revealed cell type-specific expression patterns, with hub genes predominantly expressed in neurons and microglia. These exploratory findings support a hypothetical multi-level regulatory network centered on the "energy crisis-oxidative stress-neuroinflammation" axis. Overall, this study identifies potential circulating biomarker candidates for IS and provides hypothesis-generating insights into its pathophysiological mechanisms, which may aid future research on risk stratification and therapeutic targets.</p>
10 Authors
- Ziyi Hou
- Yuanyuan Li
- Liyuan Pu
- Li Wang
- Yuanbo Jiang
- Huiqun Yang
- Xiaokun Wang
- Yongan Li
- Liyuan Han
- Qingzeng Qian
1 Application
| Application ID | Title |
|---|---|
| 78619 | Comprehensive investigation into the relationship of genetic and environmental factors with metabolic diseases and cancer |
Enabling scientific discoveries that improve human health